Who is sponsoring NCT03778190?

NCT03778190 is sponsored by Kendall Healthcare Group, Ltd..

What drugs are being tested in NCT03778190?

Interventions in NCT03778190: Corneal Foreign Body Removal.

What condition does NCT03778190 study?

NCT03778190 studies Corneal Foreign Body.

Is NCT03778190 still recruiting?

NCT03778190 is currently completed. Last updated 26 August 2020.

Are results published for NCT03778190?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2020-08-26 · How we verify

NCT03778190

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Magnet for Corneal Foreign Bodies

Completed NA Results posted Last updated 26 August 2020

What this trial tests

NA trial testing Corneal Foreign Body Removal in Corneal Foreign Body in 10 participants. Completed in 11 November 2019.

Timeline

4 December 2018

Primary endpoint
11 November 2019

11 November 2019

Quick facts

Lead sponsor	Kendall Healthcare Group, Ltd.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	4 December 2018
Primary completion	11 November 2019
Estimated completion	11 November 2019
Sites	1 location across United States

Drugs / interventions tested

Corneal Foreign Body Removal

Conditions studied

Corneal Foreign Body — all drugs for Corneal Foreign Body →

Sponsor

Kendall Healthcare Group, Ltd. — full company profile →

Who can join

18 and older, any sex, with Corneal Foreign Body. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Success Rate Primary · 5 minutes.

The percentage of patients in whom the magnet successfully removed the foreign body.

Group	Value	95% CI
Magnet	1

Epithelial Damage Secondary · 5 minutes

The percentage of patients in whom the amount of fluorescein uptake on exam was more after the procedure compared to before the procedure.

Group	Value	95% CI
Magnet	0

Sponsor's own description

This is a prospective, interventional study to assess the effectiveness and safety of a commercially available "eye magnet" to remove corneal foreign bodies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Kendall Healthcare Group, Ltd. trials

Trials by the same sponsor.

NCT04255420 — SPG Blocks for Headaches · Phase 4 · unknown
NCT04256694 — Rapid Strep Test Results · unknown
NCT04055675 — Urinalysis Results in Healthy Individuals · completed
NCT03625076 — IAL vs PS for Anterior Shoulder Dislocations · Phase 4 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03778190 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kendall Healthcare Group, Ltd.
Last refreshed: 26 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03778190.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing